In this regard, we have previously demonstrated that MEK5/ERK5 activation is associated with upregulation of the mesenchymal marker vimentin, promoting colon cancer cell invasive and metastatic behavior in an orthotopic xenograft model33. The gene discussed is MAP2K5; the disease is malignant colon neoplasm.